Recommendations of the American Association of Physicists in Medicine on 103Pd interstitial source calibration and dosimetry: implications for dose specification and prescription.
暂无分享,去创建一个
J F Williamson | R Nath | G Ibbott | B M Coursey | L A DeWerd | W F Hanson | M J Rivard | J. Williamson | G. Ibbott | B. Coursey | L. Dewerd | M. Rivard | W. Hanson | R. Nath
[1] L L Anderson,et al. A nomograph for permanent implants of palladium-103 seeds. , 1993, International journal of radiation oncology, biology, physics.
[2] T. Loftus. Exposure Standardization of Iodine-125 Seeds Used for Brachytherapy. , 1984, Journal of research of the National Bureau of Standards.
[3] K. Weaver. Anisotropy functions for 125I and 103Pd sources. , 1998, Medical physics.
[4] K. Wallner,et al. 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma. , 1996, International journal of radiation oncology, biology, physics.
[5] J. Williamson,et al. Monte Carlo modeling of the transverse-axis dose distribution of the model 200 103Pd interstitial brachytherapy source. , 2000, Medical physics.
[6] P. Unger,et al. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma , 1996, Cancer.
[7] F. Shamsa,et al. Regarding, Dattoli, Wallner, Sorace, Koval, Cash, Acosta, Brown, Etheridge, Binder, Brunelle, Kirwan, Sanchez, Stein, and Wasserman IJROBP 35(5):875-879; 1996. , 1997, International journal of radiation oncology, biology, physics.
[8] B. Prestidge,et al. Clinical impact of implementing the recommendations of AAPM Task Group 43 on permanent prostate brachytherapy using 125I. American Association of Physicists in Medicine. , 1998, International journal of radiation oncology, biology, physics.
[9] G. Ibbott,et al. On the use of apparent activity (Aapp) for treatment planning of 125I and 103Pd interstitial brachytherapy sources: recommendations of the American Association of Physicists in Medicine radiation therapy committee subcommittee on low-energy brachytherapy source dosimetry. , 1999, Medical physics.
[10] R. Firestone,et al. WWW Table of Radioactive Isotopes , 1999 .
[11] L. Anderson,et al. Functional fitting of interstitial brachytherapy dosimetry data recommended by the AAPM Radiation Therapy Committee Task Group 43. American Association of Physicists in Medicine. , 1999, Medical physics.
[12] R Nath,et al. Measurement of dose-rate constant for 103Pd seeds with air kerma strength calibration based upon a primary national standard. , 2000, Medical physics.
[13] J. Williamson,et al. Guidance to users of Nycomed Amersham and North American Scientific, Inc., I-125 interstitial sources: dosimetry and calibration changes: recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-Energy Seed Dosimetry. , 1999, Medical physics.
[14] Robert E. Wallace,et al. Dosimetric characterization of a new design 103 palladium brachytherapy source. , 1999, Medical physics.
[15] L. Anderson,et al. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 , 1995 .
[16] S. Chiu‐Tsao,et al. Thermoluminescent dosimetry for 103Pd seeds (model 200) in solid water phantom. , 1991, Medical physics.